Compare
Starco Brands, Inc. vs Stran & Company, Inc. vs Haoxi Health Technology Ltd vs Kidoz Inc.
| Latest fiscal year | Starco Brands, Inc. STCB | Stran & Company, Inc. SWAGW | Haoxi Health Technology Ltd HAO | Kidoz Inc. KDOZF |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-06-30 | 2025-12-31 |
| Revenue | n/a | $116.19M | $32.80M | $18.43M |
| Revenue growth (YoY) | n/a | +40.6% | -32.4% | +31.6% |
| Gross margin | n/a | 29.5% | 2.8% | 48.4% |
| Operating margin | n/a | -1.7% | -6.1% | 2.3% |
| Net margin | n/a | -0.6% | 11.8% | 2.5% |
| Net income | -$20.93M | -$747.0K | $3.88M | $456.8K |
| EPS (Diluted) | -$0.03 | -$0.04 | $1.32 | $0.00 |
| Operating cash flow | -$900.8K | -$4.67M | -$3.36M | $1.71M |
| Free cash flow | -$1.01M | -$5.50M | n/a | $1.68M |
| Cash & equivalents | $1.82M | $6.75M | n/a | $4.46M |
| Total assets | $35.86M | $49.35M | $21.60M | $13.17M |
| Total liabilities | $21.66M | $18.85M | $4.22M | $4.54M |
| Shareholders' equity | $5.12M | $30.50M | $17.38M | $8.64M |
| Return on year-end equity | -408.9% | -2.4% | 22.3% | 5.3% |
| Shares outstanding | n/a | 18.51M | n/a | 131.30M |
Revenue, most recent five fiscal years
| Fiscal year | Starco Brands, Inc. | Stran & Company, Inc. | Haoxi Health Technology Ltd | Kidoz Inc. |
|---|---|---|---|---|
| Latest | $65.21M Ended 2023-12-31 | $116.19M Ended 2025-12-31 | $32.80M Ended 2025-06-30 | $18.43M Ended 2025-12-31 |
| 1 year earlier | $7.81M Ended 2022-12-31 | $82.65M Ended 2024-12-31 | $48.52M Ended 2024-06-30 | $14.00M Ended 2024-12-31 |
| 2 years earlier | $673.3K Ended 2021-12-31 | $76.00M Ended 2023-12-31 | $28.23M Ended 2023-06-30 | $13.33M Ended 2023-12-31 |
| 3 years earlier | $1.37M Ended 2020-12-31 | $57.88M Ended 2022-12-31 | $16.16M Ended 2022-06-30 | $15.10M Ended 2022-12-31 |
| 4 years earlier | $240.3K Ended 2019-12-31 | $39.70M Ended 2021-12-31 | n/a | $12.48M Ended 2021-12-31 |